MedTrace Logo

VIT-ARMin Virtual, Intensified and Patient-tailored Robotic Arm Therapy With the Exoskeleton Robot ARMin

NCT02720341 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 222

Last updated 2020-10-09

No results posted yet for this study

Summary

Consideration-of-Concept Trial (stage 1) on robotic therapy of the upper extremity with the ARMin therapy robot in healthy subjects and patients with neurological disease (e.g. stroke, spinal cord injury)

Conditions

  • Stroke
  • Spinal Cord Injury
  • Healthy

Interventions

DEVICE

ARMin

single sessions of about one hour each

Sponsors & Collaborators

  • Klinik Lengg, Zurich

    collaborator OTHER

  • Swiss Federal Institute of Technology

    lead OTHER

Principal Investigators

  • Robert Riener, PhD · ETH Zurich

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-10
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02720341 on ClinicalTrials.gov